Publication date: Jan 13, 2026North Kivu, in eastern Democratic Republic of the Congo (DRC), was the epicenter of the second largest Ebola Virus Disease (EVD) outbreak in history and has ... Read more

Publication date: Jan 08, 2026Influenza is a seasonal viral respiratory disease causing significant global mortality but preventable through vaccination. Despite WHO recommendations, vaccination rates in Italy remain low due to ... Read more

Publication date: Feb 01, 2026According to WHO and UNICEF, Africa has the lowest coverage (18%) of timely (within the first 24 h) hepatitis B birth dose (HepB-BD) vaccination worldwide. To ... Read more

Publication date: Jan 10, 2026Emerging viral threats such as coronavirus, influenza, Lassa fever, Mpox, and Nipah virus continue to pose significant global health challenges. The development and deployment of effective ... Read more

Publication date: Jan 09, 2026Open Access PDF Concepts Keywords Canadian Health equity Covid Health policy Deserving Public health Vaccines SARS-CoV-2 Vaccines Semantics Type Source Name pathway REACTOME Reproduction disease MESH included disease MESH COVID 19 disease MESH infection disease MESH emergency disease MESH CCHS disease ... Read more

Publication date: Jan 08, 2026Ongoing escape from pre-existing antibodies by severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2) necessitates yearly coronavirus disease 2019 (COVID-19) vaccine updates. Monovalent variant-specific booster vaccines for ... Read more

Publication date: Feb 01, 2026Vaccine hesitancy hinders some older adults from receiving immunization against potentially life-threatening and serious diseases such as pneumonia, influenza, COVID-19, and shingles. However, vaccine hesitancy can ... Read more

Publication date: Jun 01, 2026Maintaining cold-chain integrity is vital for vaccines to ensure that they remain within the recommended temperature limits during routine storage and transportation. This ensures vaccine stability, ... Read more

Publication date: Jan 09, 2026MVA-MERS-S, a vaccine candidate against Middle East respiratory syndrome (MERS), was recently evaluated in a randomized, placebo-controlled, double-blind phase 1b clinical trial to assess its safety, ... Read more

Publication date: Jan 08, 2026Papua New Guinea (PNG) has one of the world’s lowest COVID-19 vaccination rates, despite high awareness of the disease. Understanding the behavioural and social drivers of ... Read more